1-2 of 2
Nancy Kernan, M.D.
Close
Sort by
Journal Articles

Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC).

Paul G Richardson, Gideon Steinbach, M.D., Nancy Kernan, M.D., Eva C. Guinan, MD, Allen R. Chen, MD, PhD, MHS, Paul L Martin, MD, PhD, Amrita Krishnan, M.D., Sally Arai, MD, Joel A. Brochstein, MD, Stephan A. Grupp, M.D., Ph.D., Shin Mineishi, M.D., Amanda Termuhlen, MD, Marcie Tomblyn, MD, MS, Joseph H. Antin, MD, Carolyn Revta, Robin Hume, M.S., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, MD, Robert J Soiffer, MD, Defibrotide Study Group
Journal: Blood
Blood (2010) 116 (21): 3481.
https://doi.org/10.1182/blood.V116.21.3481.3481
Published: 2010
Journal Articles

Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control.

Paul Richardson, M.D., Marcie Tomblyn, MD, MS, Nancy Kernan, M.D., Joel A. Brochstein, MD, Shin Mineishi, MD, Amanda Termuhlen, MD, Sally Arai, MD, Stephan A. Grupp, MD, PhD, Eva Guinan, M.D., Paul L. Martin, MD, PhD, Selim Corbacioglu, MD, Ernst Holler, M.D., Ralph D'Agostino, Ph.D., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, M.D., Robert J Soiffer, MD
Journal: Blood
Blood (2009) 114 (22): 654.
https://doi.org/10.1182/blood.V114.22.654.654
Published: 2009